Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with type 2 diabetes
Authors:
Open Access
- 5 November 2005
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 48 (12) , 2602-2608
Abstract
Aims/hypothesis Nitric oxide (NO) has been implicated as an important signalling molecule in the contraction-mediated glucose uptake pathway and may represent a novel strategy for blood glucose control. The current study sought to determine whether acute infusion of the NO donor, sodium nitroprusside (SNP), increases leg glucose uptake at rest in patients with type 2 diabetes. Methods Fifteen male patients with type 2 diabetes (aged 54±4 years, mean±SD) were entered into a randomised, cross-over design study, examining the effect of a 30-min intra-femoral infusion of SNP on leg glucose uptake. Comparison was made with a 30-min infusion of verapamil, titrated to elicit similar leg blood flow responses to SNP. Leg blood flow was measured by thermodilution in the femoral vein, and leg glucose uptake was calculated as the product of leg blood flow and the femoral arterio–venous (A-V) glucose concentration gra0dient. Results The two drugs increased leg blood flow to a similar extent (p=0.50). Both leg A-V glucose concentration gradient (SNP 0.12±0.05, verapamil −0.06±0.04 mmol/l; mean± SEM, p=0.03) and leg glucose uptake (SNP 0.17±0.09, verapamil −0.09±0.06 mmol/min; p=0.03) were higher with the SNP treatment than with verapamil. These results occurred independently of any significant difference in plasma insulin concentration between drugs (p=0.56). Conclusions/interpretation Acute infusion of SNP resulted in greater glucose uptake relative to verapamil. NO may therefore be an important mediator of peripheral glucose disposal and a potential therapeutic target in patients with type 2 diabetes.Keywords
This publication has 50 references indexed in Scilit:
- Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Insulin Stimulates Glucose Transport Via Nitric Oxide/Cyclic GMP Pathway in Human Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Does Nitric Oxide Mediate the Vasodilator Activity of Nitroglycerin?Circulation Research, 2003
- Evidence that Nitroprusside Stimulates Glucose Uptake in Isolated Rat Cardiomyocytes via Mitogen-activated Protein KinaseArchives of Physiology and Biochemistry, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric OxideCirculation Research, 2002
- Wortmannin inhibits insulin‐stimulated but not contraction‐stimulated glucose transport activity in skeletal muscleFEBS Letters, 1995
- Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.Journal of Clinical Investigation, 1992
- Assessment of the composition of major body regions by dual‐energy X‐ray absorptiometry (DEXA), with special reference to limb muscle massClinical Physiology and Functional Imaging, 1992
- Effects of Calcium Antagonists on Glucose Homeostasis and Serum Lipids in Non-Diabetic and Diabetic Subjects: A ReviewJournal Of Hypertension, 1987